|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07K 14/605 | (2006.01) |
| C07K 14/765 | (2006.01) | ||
| C12N 15/62 | (2006.01) | ||
| A61K 38/38 | (2006.01) | ||
| A61K 38/26 | (2006.01) | ||
| C07K 19/00 | (2006.01) | ||
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 1724284 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06118975.9 |
| Date of filing the European patent application | 2001-11-29 | |
| (97) | Date of publication of the European application | 2006-11-22 |
| (45) | Date of publication and mention of the grant of the patent | 2009-07-29 |
| (46) | Date of publication of the claims translation | 2009-11-25 |
| (30) | Number | Date | Country code |
| 251954 P | 2000-12-07 | US |
| (72) |
Glaesner, Wolfgang, US
Micanovic, Radmila, US
Tschang, Sheng-Hung Rainbow, US
|
| (73) |
Eli Lilly & Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | GLP-1 sulieti baltymai |
| GLP-1 fusion proteins |
| Payment date | Validity (years) | Amount | |
| 2020-11-12 | 347.00 EUR |